Ask your AI client

Use GeneFoundry to assess MYH7 gene-disease validity. List each ClinGen disease, inheritance, evidence strength, curator and date; compare GenCC submissions for the same disease identifiers. Explain which relationships are definitive and which remain limited, without classifying a patient variant.

The result

ClinGen returned three Definitive and two Limited MYH7 relationships, all autosomal dominant. GenCC returned all 11 disease groups and 21 submissions from five submitters; its strongest-per-gene label conceals this disease-specific variation.

All five ClinGen MYH7 validity assertions
Disease / identifierInheritanceValidityExpert panelClassification date
MYH7-related skeletal myopathy · MONDO:0008050Autosomal dominantDefinitiveCongenital Myopathies and Myasthenic Syndromes Gene Curation Expert Panel2021-05-13
arrhythmogenic right ventricular cardiomyopathy · MONDO:0016587Autosomal dominantLimitedArrhythmogenic Right Ventricular Cardiomyopathy Gene Curation Expert Panel2019-08-06
congenital heart disease · MONDO:0005453Autosomal dominantLimitedCongenital Heart Disease Gene Curation Expert Panel2024-02-12
dilated cardiomyopathy 1S · MONDO:0013262Autosomal dominantDefinitiveDilated Cardiomyopathy Gene Curation Expert Panel2026-03-04
hypertrophic cardiomyopathy · MONDO:0005045Autosomal dominantDefinitiveHereditary Cardiovascular Disease Gene Curation Expert Panel2023-07-12
GenCC disease groups · each submitter’s assertion retained
Disease / identifierSubmitter: classification / inheritance / date
MYH7-related skeletal myopathy · MONDO:0008050ClinGen: Definitive / Autosomal dominant / 2021-05-13; Ambry Genetics: Strong / Autosomal dominant / 2017-05-19; Labcorp Genetics (formerly Invitae): Strong / Autosomal dominant / 2022-01-13; Orphanet: Supportive / Autosomal dominant / 2021-09-14
dilated cardiomyopathy 1S · MONDO:0013262ClinGen: Definitive / Autosomal dominant / 2026-03-04; G2P: Definitive / Autosomal dominant / 2024-03-20; Ambry Genetics: Strong / Autosomal dominant / 2020-03-31; Labcorp Genetics (formerly Invitae): Strong / Autosomal dominant / 2023-06-01
hypertrophic cardiomyopathy · MONDO:0005045ClinGen: Definitive / Autosomal dominant / 2023-07-12
hypertrophic cardiomyopathy 1 · MONDO:0008647Ambry Genetics: Definitive / Autosomal dominant / 2017-05-19; G2P: Definitive / Autosomal dominant / 2024-03-20; Labcorp Genetics (formerly Invitae): Strong / Autosomal dominant / 2023-01-27
myopathy, myosin storage, autosomal recessive · MONDO:0009708Labcorp Genetics (formerly Invitae): Strong / Autosomal recessive / 2019-05-28; Ambry Genetics: Moderate / Autosomal recessive / 2020-03-30
myopathy, myosin storage, autosomal dominant · MONDO:0012018Ambry Genetics: Moderate / Autosomal dominant / 2020-03-31
Ebstein anomaly · MONDO:0009144Orphanet: Supportive / Autosomal dominant / 2021-09-14
familial isolated dilated cardiomyopathy · MONDO:0015470Orphanet: Supportive / Autosomal dominant / 2021-09-14
left ventricular noncompaction · MONDO:0018901Orphanet: Supportive / Autosomal dominant / 2021-09-14
arrhythmogenic right ventricular cardiomyopathy · MONDO:0016587ClinGen: Limited / Autosomal dominant / 2019-08-06; G2P: Limited / Autosomal dominant / 2025-09-25
congenital heart disease · MONDO:0005453ClinGen: Limited / Autosomal dominant / 2024-02-12

ClinGen: MYH7-related skeletal myopathy, dilated cardiomyopathy 1S and hypertrophic cardiomyopathy are Definitive; arrhythmogenic right ventricular cardiomyopathy and congenital heart disease are Limited. These are separate disease-specific assessments.

GenCC reports has_conflict=false, yet submitted strengths differ (for example Strong, Definitive and Supportive for skeletal myopathy). The flag is not unanimity and the submissions are not independent votes.

GenCC separately lists autosomal recessive and autosomal dominant myosin-storage myopathy. Preserve those inheritance-specific relationships rather than merging them under the MYH7 gene label.

No patient phenotype or variant was evaluated. Use the relevant disease relationship to guide subsequent variant-mechanism review.

Original source records
How GeneFoundry got this
  1. Resolve MYH7

    Resolve the exact gene symbol before comparing curated relationships.

    gencc_resolve_identifier

    {
      "query": "MYH7",
      "kind": "gene"
    }
  2. Read each ClinGen disease relationship

    Retrieve all five validity assertions, keeping disease, inheritance, curator and date together.

    clingen_get_gene_validity

    {
      "gene_symbol": "MYH7",
      "response_mode": "full"
    }
  3. Compare submitter assertions in GenCC

    Retrieve all 11 disease groups and their 21 submissions; compare the actual disease identifiers and inheritance before comparing strengths.

    gencc_get_gene_curations

    {
      "gene_symbol": "HGNC:7577",
      "response_mode": "full",
      "limit": 200,
      "offset": 0
    }

A definitive gene-disease relationship does not establish that any particular MYH7 variant is pathogenic or that a patient has that disease.

Disease labels may reflect different grouping policies. Compare identifiers, phenotype scope, inheritance and original evidence before merging records.